chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Product selection error
Clinical narrative: Dose is considered invalid; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT SELECTION ERROR (Dose is considered invalid) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced PRODUCT SELECTION ERROR (Dose is considered invalid). At the time of the report, PRODUCT SELECTION ERROR (Dose is considered invalid) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported No treatment medications were reported    This case was linked to US-MODERNATX, INC.-MOD-2021-100428 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-100428:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus, Pyrexia
Clinical narrative: Arm is red and swollen and itchy; Arm is red and swollen and itchy; Arm is red and swollen and itchy; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm is red and swollen and itchy), PRURITUS (Arm is red and swollen and itchy), ERYTHEMA (Arm is red and swollen and itchy) and PYREXIA (Fever) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced PERIPHERAL SWELLING (Arm is red and swollen and itchy), PRURITUS (Arm is red and swollen and itchy), ERYTHEMA (Arm is red and swollen and itchy) and PYREXIA (Fever). At the time of the report, PERIPHERAL SWELLING (Arm is red and swollen and itchy), PRURITUS (Arm is red and swollen and itchy) and ERYTHEMA (Arm is red and swollen and itchy) had not resolved and PYREXIA (Fever) outcome was unknown.            No concomitant medication was reported.  Treatment medication was not provided
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm after first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm after first dose) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A,) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL + HIDROCLOROTIAZIDA), FERROUS SULFATE and OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm after first dose). At the time of the report, PAIN IN EXTREMITY (sore arm after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal rigidity, Hepatic pain, Myalgia, Nausea, Pyrexia
Clinical narrative: pain at the site of the injection; Body aches; Fever; severe nausea; stomach spasm in increasing intensity; severe pain in the liver; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL RIGIDITY (stomach spasm in increasing intensity), HEPATIC PAIN (severe pain in the liver), VACCINATION SITE PAIN (pain at the site of the injection), MYALGIA (Body aches) and NAUSEA (severe nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016C21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced ABDOMINAL RIGIDITY (stomach spasm in increasing intensity) and HEPATIC PAIN (severe pain in the liver). 30-Apr-2021, the patient experienced NAUSEA (severe nausea). On 01-May-2021, the patient experienced VACCINATION SITE PAIN (pain at the site of the injection), MYALGIA (Body aches) and PYREXIA (Fever). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) for Hepatic pain and Abdominal spasm, at an unspecified dose and frequency. On 01-May-2021, HEPATIC PAIN (severe pain in the liver) had resolved. At the time of the report, ABDOMINAL RIGIDITY (stomach spasm in increasing intensity), VACCINATION SITE PAIN (pain at the site of the injection), MYALGIA (Body aches), NAUSEA (severe nausea) and PYREXIA (Fever) outcome was unknown.            No concomitant medications were reported.  The action taken with mRNA-1273 in response to the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain at the site of the injection; Body aches; Fever; severe nausea; stomach spasm in increasing intensity; severe pain in the liver; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL RIGIDITY (stomach spasm in increasing intensity), HEPATIC PAIN (severe pain in the liver), VACCINATION SITE PAIN (pain at the site of the injection), MYALGIA (Body aches) and NAUSEA (severe nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016C21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced ABDOMINAL RIGIDITY (stomach spasm in increasing intensity) and HEPATIC PAIN (severe pain in the liver). 30-Apr-2021, the patient experienced NAUSEA (severe nausea). On 01-May-2021, the patient experienced VACCINATION SITE PAIN (pain at the site of the injection), MYALGIA (Body aches) and PYREXIA (Fever). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) for Hepatic pain and Abdominal spasm, at an unspecified dose and frequency. On 01-May-2021, HEPATIC PAIN (severe pain in the liver) had resolved. At the time of the report, ABDOMINAL RIGIDITY (stomach spasm in increasing intensity), VACCINATION SITE PAIN (pain at the site of the injection), MYALGIA (Body aches), NAUSEA (severe nausea) and PYREXIA (Fever) outcome was unknown.            No concomitant medications were reported.  The action taken with mRNA-1273 in response to the event was not applicable.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Lymphadenopathy, Myalgia, Nausea
Clinical narrative: fatigue; chills; muscle pain; nausea; vomiting; soreness in arm at injection site; glands by throat swollen; received Pfizer as 1st dose instead of Moderna COVID19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION ERROR ( received Pfizer as 1st dose instead of Moderna COVID19 vaccine), FATIGUE (fatigue), CHILLS (chills), MYALGIA (muscle pain) and NAUSEA (nausea) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025E21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced PRODUCT ADMINISTRATION ERROR ( received Pfizer as 1st dose instead of Moderna COVID19 vaccine). On 29-Apr-2021, the patient experienced FATIGUE (fatigue), CHILLS (chills), MYALGIA (muscle pain), NAUSEA (nausea), VOMITING (vomiting), VACCINATION SITE PAIN (soreness in arm at injection site) and LYMPHADENOPATHY (glands by throat swollen). At the time of the report, PRODUCT ADMINISTRATION ERROR  received Pfizer as 1st dose instead of Moderna COVID19 vaccine) had resolved and FATIGUE (fatigue), CHILLS (chills), MYALGIA (muscle pain), NAUSEA (nausea), VOMITING (vomiting), VACCINATION SITE PAIN (soreness in arm at injection site) and LYMPHADENOPATHY (glands by throat swollen) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported No treatment medications were reported
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Product administration error, Vaccination site pain, Vomiting
Clinical narrative: fatigue; chills; muscle pain; nausea; vomiting; soreness in arm at injection site; glands by throat swollen; received Pfizer as 1st dose instead of Moderna COVID19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION ERROR ( received Pfizer as 1st dose instead of Moderna COVID19 vaccine), FATIGUE (fatigue), CHILLS (chills), MYALGIA (muscle pain) and NAUSEA (nausea) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025E21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced PRODUCT ADMINISTRATION ERROR ( received Pfizer as 1st dose instead of Moderna COVID19 vaccine). On 29-Apr-2021, the patient experienced FATIGUE (fatigue), CHILLS (chills), MYALGIA (muscle pain), NAUSEA (nausea), VOMITING (vomiting), VACCINATION SITE PAIN (soreness in arm at injection site) and LYMPHADENOPATHY (glands by throat swollen). At the time of the report, PRODUCT ADMINISTRATION ERROR  received Pfizer as 1st dose instead of Moderna COVID19 vaccine) had resolved and FATIGUE (fatigue), CHILLS (chills), MYALGIA (muscle pain), NAUSEA (nausea), VOMITING (vomiting), VACCINATION SITE PAIN (soreness in arm at injection site) and LYMPHADENOPATHY (glands by throat swollen) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported No treatment medications were reported
Sex: U
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Her friend broke out into hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Her friend broke out into hives) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided by the reporter.     On 01-Jan-1900, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Her friend broke out into hives). The patient was treated with PREDNISONE for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (Her friend broke out into hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.   Reporter did not allow further contact
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Blood pressure increased
Clinical narrative: Blood pressure was 157/90 when normally is 120/80; blood pressure still remains a little high (in the 135 to 145 over 85 range); This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE ABNORMAL (Blood pressure was 157/90 when normally is 120/80) and BLOOD PRESSURE INCREASED (blood pressure still remains a little high (in the 135 to 145 over 85 range)) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), COLECALCIFEROL (VITAMIN D SUPPORT) and TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF) for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE ABNORMAL (Blood pressure was 157/90 when normally is 120/80) and BLOOD PRESSURE INCREASED (blood pressure still remains a little high (in the 135 to 145 over 85 range)). At the time of the report, BLOOD PRESSURE ABNORMAL (Blood pressure was 157/90 when normally is 120/80) was resolving and BLOOD PRESSURE INCREASED (blood pressure still remains a little high (in the 135 to 145 over 85 range)) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication include statin group of drug.  No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow up received, an adverse event was added.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Incomplete course of vaccination
Clinical narrative: Patient feels he was not given second vaccine dose because it was quick needle prick; This spontaneous case was reported by a consumer and describes the occurrence of INCOMPLETE COURSE OF VACCINATION (Patient feels he was not given second vaccine dose because it was quick needle prick) in a 68-year-old male patient who received mRNA-1273 (batch nos. 004621A and 025B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced INCOMPLETE COURSE OF VACCINATION (Patient feels he was not given second vaccine dose because it was quick needle prick). On 29-Apr-2021, INCOMPLETE COURSE OF VACCINATION (Patient feels he was not given second vaccine dose because it was quick needle prick) had resolved.            No treatment medication was reported No concomitant medication was provided Action taken with mRNA-1273 in response to the events were Not Applicable
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Influenza like illness, Pyrexia
Clinical narrative: flu like symptoms; sick for 36 degrees; Got the second vaccine after two months; This spontaneous case was reported by a nurse and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got the second vaccine after two months) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 013L20A) for COVID-19 vaccination.     Concomitant products included VITAMIN D NOS, CURCUMIN and COENZYME Q10 [UBIDECARENONE] for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021 at 11:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got the second vaccine after two months). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got the second vaccine after two months) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   This case was linked to MOD-2021-027721, MOD-2021-101354  (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Therapeutic response unexpected
Clinical narrative: dizziness; weakness; the second dose ook the inflammation out of my lungs and I can breathe normally for the first time in months; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), ASTHENIA (weakness) and THERAPEUTIC RESPONSE UNEXPECTED (the second dose ook the inflammation out of my lungs and I can breathe normally for the first time in months) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COVID-19.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), ASTHENIA (weakness) and THERAPEUTIC RESPONSE UNEXPECTED (the second dose ook the inflammation out of my lungs and I can breathe normally for the first time in months). At the time of the report, DIZZINESS (dizziness) and ASTHENIA (weakness) had not resolved and THERAPEUTIC RESPONSE UNEXPECTED (the second dose ook the inflammation out of my lungs and I can breathe normally for the first time in months) outcome was unknown.            No concomitant medications were reported Treatment information was not provided Action taken with mRNA-1273 in response to the events were Not Applicable
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 007C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm). At the time of the report, PAIN IN EXTREMITY (Pain in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment information not provided   This case was linked to MOD-2021-100480 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Fever; Chills; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body ache) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body ache). At the time of the report, PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  No treatment information provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood pressure measurement, Fatigue, Night sweats, Vaccination site pain
Clinical narrative: Night sweats; late in the day soreness in the arm at injection site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (Night sweats), VACCINATION SITE PAIN (late in the day soreness in the arm at injection site) and FATIGUE (Fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 047A21A) for COVID-19 vaccination.     The patient's past medical history included Type II diabetes mellitus. Concomitant products included METFORMIN and GLYBURIDE for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced VACCINATION SITE PAIN (late in the day soreness in the arm at injection site) and FATIGUE (Fatigue). On 25-Apr-2021, the patient experienced NIGHT SWEATS (Night sweats). On 24-Apr-2021, VACCINATION SITE PAIN (late in the day soreness in the arm at injection site) had resolved. At the time of the report, NIGHT SWEATS (Night sweats) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Apr-2021, Blood glucose: 100 (Inconclusive) blood sugar levels were in the 100's some 90's. On an unknown date, Blood glucose: 195 to 95 (Inconclusive) blood sugar went down as from 195 to 95. On an unknown date, Blood pressure measurement: 122/80 (normal) normal.         No treatment medications were provided. Action taken with mRNA-1273 in response to the events was not Applicable Patient had cured Type II diabetes after the first dose of Moderna's vaccine Patient reported of normal blood pressure and had colonoscopy   This case was linked to MOD-2021-100822 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Follow-up information received on 31-May-2021 contains non-significant information. On 31-May-2021: Follow-up information received on 31-May-2021 contains Added new event (fatigue) and lab data.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of dizziness and fatigue (tired) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 002A21A) for COVID-19 immunization. Concurrent medical conditions included blood pressure management. On Feb 24, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 24, 2021, received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Feb 24, 2021, patient experienced dizziness and fatigue (tired). At the time of the report, dizziness and fatigue (tired) resolved. The reporter did not provide any causality assessments. Concomitant medication included blood pressure medication. Treatment information not reported. Action taken with mRNA-1273 in response to the event: not applicable. This case linked to MOD-2021-100757 (patient link). Most recent follow-up information incorporated: On May 31, 2021: Follow-up document attached contained updated outcome: recovered.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure management
Clinical narrative: Increased blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (Increased blood pressure) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE INCREASED (Increased blood pressure). At the time of the report, BLOOD PRESSURE INCREASED (Increased blood pressure) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure management (120-80): 122/73 (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow-up information received on 20 Jul 2021 contains updated event outcome to recovering/resolving.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Axillary pain, Chest pain, Cold sweat, Dizziness
Clinical narrative: they reacted to the vaccine; Painful lump under armpit; Painful lump under armpit; cold sweats at night; dizziness; chest pain; sore throat; losing voice; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), OROPHARYNGEAL PAIN (sore throat), APHONIA (losing voice), AXILLARY PAIN (Painful lump under armpit) and COLD SWEAT (cold sweats at night) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced CHEST PAIN (chest pain), OROPHARYNGEAL PAIN (sore throat), APHONIA (losing voice), DIZZINESS (dizziness) and HEADACHE (bad headache). On 08-May-2021, the patient experienced AXILLARY PAIN (Painful lump under armpit), COLD SWEAT (cold sweats at night) and MASS (Painful lump under armpit). On an unknown date, the patient experienced VACCINATION COMPLICATION (they reacted to the vaccine). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, CHEST PAIN (chest pain), OROPHARYNGEAL PAIN (sore throat), APHONIA (losing voice), AXILLARY PAIN (Painful lump under armpit), COLD SWEAT (cold sweats at night), DIZZINESS (dizziness), MASS (Painful lump under armpit), VACCINATION COMPLICATION (they reacted to the vaccine) and HEADACHE (bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was unknown   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow up information received : new event info updated.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Mass, Oropharyngeal pain, Vaccination complication
Clinical narrative: they reacted to the vaccine; Painful lump under armpit; Painful lump under armpit; cold sweats at night; dizziness; chest pain; sore throat; losing voice; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), OROPHARYNGEAL PAIN (sore throat), APHONIA (losing voice), AXILLARY PAIN (Painful lump under armpit) and COLD SWEAT (cold sweats at night) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced CHEST PAIN (chest pain), OROPHARYNGEAL PAIN (sore throat), APHONIA (losing voice), DIZZINESS (dizziness) and HEADACHE (bad headache). On 08-May-2021, the patient experienced AXILLARY PAIN (Painful lump under armpit), COLD SWEAT (cold sweats at night) and MASS (Painful lump under armpit). On an unknown date, the patient experienced VACCINATION COMPLICATION (they reacted to the vaccine). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, CHEST PAIN (chest pain), OROPHARYNGEAL PAIN (sore throat), APHONIA (losing voice), AXILLARY PAIN (Painful lump under armpit), COLD SWEAT (cold sweats at night), DIZZINESS (dizziness), MASS (Painful lump under armpit), VACCINATION COMPLICATION (they reacted to the vaccine) and HEADACHE (bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was unknown   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow up information received : new event info updated.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Exposure via breast milk, Pain
Clinical narrative: Left Arm throbbing; Little bruise on left arm; breastfeeding mom; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (breastfeeding mom), PAIN (Left Arm throbbing) and CONTUSION (Little bruise on left arm) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced EXPOSURE VIA BREAST MILK (breastfeeding mom). On an unknown date, the patient experienced PAIN (Left Arm throbbing) and CONTUSION (Little bruise on left arm). At the time of the report, EXPOSURE VIA BREAST MILK (breastfeeding mom), PAIN (Left Arm throbbing) and CONTUSION (Little bruise on left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided No concomitant medications were provided Action taken with mRNA-1273 is unknown   This case was linked to MOD-2021-100806, MOD-2021-100806 (Parent-Child Link).   See case MOD-2021-100806,MOD-2021-100806 for details regarding the child case.
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Hypertension
Clinical narrative: hypertension; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (hypertension) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (hypertension). At the time of the report, HYPERTENSION (hypertension) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 133/79 (Low) 133/79 mmHg and high (High) high.         No Concomitant medications were reported. No treatment medications were reported. Action taken with mRNA-1273 in response to the events were Not Applicable.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow-up received on 15-JUN-2021- Outcome of event updated, lab data updated.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia, Pyrexia
Clinical narrative: Severe body aches; Started in her left shoulder; Head hurts bad; Low-grade fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Severe body aches), ARTHRALGIA (started in her left shoulder), HEADACHE (head hurts bad) and PYREXIA (low-grade fever) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Severe body aches), ARTHRALGIA (started in her left shoulder), HEADACHE (head hurts bad) and PYREXIA (low-grade fever). At the time of the report, MYALGIA (Severe body aches), ARTHRALGIA (started in her left shoulder), HEADACHE (head hurts bad) and PYREXIA (low-grade fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided.  On an unknown date, the patient stated the body aches were so bad she could not get out of bed.  No treatment information provided.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Rash
Clinical narrative: rash spots all over body/ appears during night time and disappears during day time; achy; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (achy) and RASH (rash spots all over body/ appears during night time and disappears during day time) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced MYALGIA (achy). On 27-Apr-2021, the patient experienced RASH (rash spots all over body/ appears during night time and disappears during day time). On 23-Apr-2021, MYALGIA (achy) had resolved. At the time of the report, RASH (rash spots all over body/ appears during night time and disappears during day time) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant product included OMEGA 3 OIL for an unknown indication Treatment included BENADRYL and OTC PREDNISONE
Age: 60.0
Sex: F
Vaccine: COVID19, UNK, UNK
Symptoms: Influenza like illness, Palpitations
Clinical narrative: Heart palpitations; Flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart palpitations) and INFLUENZA LIKE ILLNESS (Flu-like symptoms) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect products included non-company products MACITENTAN (OPSUMIT) for an unknown indication and TREPROSTINIL SODIUM (REMODULIN) for Pulmonary hypertension.    Concurrent medical conditions included Pulmonary hypertension (secondary pulmonary arterial hypertension). Concomitant products included RIOCIGUAT (ADEMPAS) for an unknown indication.   On 15-Aug-2019, the patient started TREPROSTINIL SODIUM (REMODULIN) (Subcutaneous) .068 microgram/kilogram. On 20-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started MACITENTAN (OPSUMIT) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced PALPITATIONS (Heart palpitations) and INFLUENZA LIKE ILLNESS (Flu-like symptoms). At the time of the report, PALPITATIONS (Heart palpitations) and INFLUENZA LIKE ILLNESS (Flu-like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  Patient was on Remodulin since 15AUG2019 for secondary pulmonary arterial hypertension. On an unreported date in Apr 2021, the patient experienced the events of heart palpitations (palpitations) and flu like symptoms after COVID vaccination.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Erythema, Headache, Malaise, Pain in extremity
Clinical narrative: body ache; malaise; fever 101°F; Huge red patch; Itchiness; Arm pain; Headache; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of MALAISE (body ache; malaise) and PYREXIA (fever 101°F) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M201 and 032L20A) for an unknown indication.     No relevant medical history was reported. The patient has no known allergies.  Concomitant products included LETROZOLE for Prophylaxis.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced MALAISE (body ache; malaise) and PYREXIA (fever 101°F). On 04-Mar-2021, MALAISE (body ache; malaise) and PYREXIA (fever 101°F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Body temperature: 101 (High) 101 degrees Fahrenheit.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered MALAISE (body ache; malaise) and PYREXIA (fever 101°F) to be possibly related.    The patient is a physician who self-treated with ibuprofen 400mg on the second night and the events resolved.   This case was linked to MOD-2021-027515 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia
Clinical narrative: body ache; malaise; fever 101°F; Huge red patch; Itchiness; Arm pain; Headache; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of MALAISE (body ache; malaise) and PYREXIA (fever 101°F) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M201 and 032L20A) for an unknown indication.     No relevant medical history was reported. The patient has no known allergies.  Concomitant products included LETROZOLE for Prophylaxis.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced MALAISE (body ache; malaise) and PYREXIA (fever 101°F). On 04-Mar-2021, MALAISE (body ache; malaise) and PYREXIA (fever 101°F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Body temperature: 101 (High) 101 degrees Fahrenheit.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered MALAISE (body ache; malaise) and PYREXIA (fever 101°F) to be possibly related.    The patient is a physician who self-treated with ibuprofen 400mg on the second night and the events resolved.   This case was linked to MOD-2021-027515 (Patient Link).
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: change in menstrual cycle of about a week; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (change in menstrual cycle of about a week) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced MENSTRUATION IRREGULAR (change in menstrual cycle of about a week). At the time of the report, MENSTRUATION IRREGULAR (change in menstrual cycle of about a week) outcome was unknown. Not Provided
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired product administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired product administered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired product administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired product administered) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow up received on 20-July-2021 content no new information
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Dyskinesia, Erythema, Peripheral swelling
Clinical narrative: Right arm got swelled up; Blisters on right arm; Red ring on right arm; Could not lift right arm to head area; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Right arm got swelled up), BLISTER (Blisters on right arm), ERYTHEMA (Red ring on right arm) and DYSKINESIA (Could not lift right arm to head area) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), LISINOPRIL and BUSPIRONE HCL for an unknown indication.    On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced PERIPHERAL SWELLING (Right arm got swelled up), BLISTER (Blisters on right arm), ERYTHEMA (Red ring on right arm) and DYSKINESIA (Could not lift right arm to head area). On 26-Apr-2021, PERIPHERAL SWELLING (Right arm got swelled up), BLISTER (Blisters on right arm), ERYTHEMA (Red ring on right arm) and DYSKINESIA (Could not lift right arm to head area) had resolved. Not Provided   Treatment medication included Doxycycline.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    This case was linked to US-MODERNATX, INC.-MOD-2021-101407 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-101407:First dose case
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B212A and 007C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.            No concomitant medications were provided No treatment medications were provided Action taken with mRNA-1273 is not applicable
Age: 62.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Parosmia, Rheumatoid arthritis, Urticaria
Clinical narrative: Rheumatoid Arthritis flare up; Smell alteration; Hives; This spontaneous case was reported by a physician and describes the occurrence of RHEUMATOID ARTHRITIS (Rheumatoid Arthritis flare up), PAROSMIA (Smell alteration) and URTICARIA (Hives) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    No Medical History information was reported.   In April 2021, the patient ADALIMUMAB (HUMIRA) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced RHEUMATOID ARTHRITIS (Rheumatoid Arthritis flare up), PAROSMIA (Smell alteration) and URTICARIA (Hives). At the time of the report, RHEUMATOID ARTHRITIS (Rheumatoid Arthritis flare up) had not resolved and PAROSMIA (Smell alteration) and URTICARIA (Hives) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable  Humira was stopped on an unknown date in 2021 and resumed on an unknown date in April 2021.  Very limited information regarding these events has been provided at this time. The rheumatoid arthritis flare may not be unrelated to the patient's medical history. A causal relationship cannot be excluded for the events of parosmia and urticaria.  Upon internal review on 21 May 2021, Humira was updated to a co-suspect drug and narrative was updated.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow up received on 22-Jun-2021 as event outcome of hives and Parosmia (from recovering to recovered) was updated.; Sender's Comments: Very limited information regarding these events has been provided at this time. The rheumatoid arthritis flare may not be unrelated to the patient's medical history. A causal relationship cannot be excluded for the events of parosmia and urticaria.
Sex: M
Vaccine: COVID19
Symptoms: Blister, Herpes zoster
Clinical narrative: Shingle-like blistering; Shingle-like blistering; This spontaneous case was reported by a non-health professional (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Shingle-like blistering) and BLISTER (Shingle-like blistering) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingle-like blistering) and BLISTER (Shingle-like blistering). At the time of the report, HERPES ZOSTER (Shingle-like blistering) and BLISTER (Shingle-like blistering) outcome was unknown.            No concomitant medicines were reported. No treatment information were reported. Follow up received on 27-JUL-2021 included no new information.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Non-significant FU - patient email address provided.